Simcere Pharmaceutical Group Limited (2096.HK)

HKD 8.99

(2.63%)

Total Assets Summary of Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited's latest annual total assets in 2023 was 10.85 Billion CNY , up 0.67% from previous year.
Simcere Pharmaceutical Group Limited's latest quarterly total assets in 2024 Q1 was 11.71 Billion CNY , up 7.92% from previous quarter.
Simcere Pharmaceutical Group Limited reported annual total assets of 10.78 Billion CNY in 2022, up 6.1% from previous year.
Simcere Pharmaceutical Group Limited reported annual total assets of 10.16 Billion CNY in 2021, down -7.15% from previous year.
Simcere Pharmaceutical Group Limited reported quarterly total assets of 11.71 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Simcere Pharmaceutical Group Limited reported quarterly total assets of 10.85 Billion CNY for 2023 Q3, down -14.47% from previous quarter.

Annual Total Assets Chart of Simcere Pharmaceutical Group Limited (2023 - 2012)

Historical Annual Total Assets of Simcere Pharmaceutical Group Limited (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	10.85 Billion CNY	0.67%
2022	10.78 Billion CNY	6.1%
2021	10.16 Billion CNY	-7.15%
2020	10.94 Billion CNY	61.72%
2019	6.76 Billion CNY	6.76%
2018	6.33 Billion CNY	22.01%
2017	5.19 Billion CNY	0.0%
2012	3.37 Billion CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	11.71 Billion CNY	7.92%
2024 Q2	11.71 Billion CNY	0.0%
2023 Q3	10.85 Billion CNY	-14.47%
2023 Q4	10.85 Billion CNY	0.0%
2023 FY	10.85 Billion CNY	0.67%
2023 Q1	12.68 Billion CNY	17.7%
2023 Q2	12.68 Billion CNY	0.0%
2022 FY	10.78 Billion CNY	6.1%
2022 Q4	10.78 Billion CNY	-0.07%
2022 Q3	10.78 Billion CNY	8.54%
2022 Q2	9.94 Billion CNY	0.0%
2022 Q1	9.94 Billion CNY	-2.18%
2021 Q3	10.16 Billion CNY	2.16%
2021 Q2	9.94 Billion CNY	0.0%
2021 Q1	9.94 Billion CNY	-9.11%
2021 FY	10.16 Billion CNY	-7.15%
2021 Q4	10.16 Billion CNY	0.0%
2020 Q4	10.94 Billion CNY	0.0%
2020 Q2	7.75 Billion CNY	0.0%
2020 Q1	7.75 Billion CNY	14.57%
2020 FY	10.94 Billion CNY	61.72%
2020 Q3	10.94 Billion CNY	41.16%
2019 Q4	6.76 Billion CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	6.76 Billion CNY	6.76%
2019 Q3	6.76 Billion CNY	0.0%
2018 FY	6.33 Billion CNY	22.01%
2017 FY	5.19 Billion CNY	0.0%
2013 Q1	3.4 Billion CNY	0.88%
2013 Q3	4.03 Billion CNY	5.84%
2013 Q2	3.8 Billion CNY	11.94%
2012 Q4	3.37 Billion CNY	-1.2%
2012 FY	3.37 Billion CNY	0.0%
2012 Q1	- CNY	0.0%
2012 Q2	- CNY	0.0%
2012 Q3	3.41 Billion CNY	0.0%

Peer Total Assets Comparison of Simcere Pharmaceutical Group Limited

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-2547.288%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	3.501%